Cryoprecipitate
Sponsors
CSL Behring, University of Sao Paulo, Weill Medical College of Cornell University, Gold Coast Hospital and Health Service, Stanford University
Conditions
Acquired Fibrinogen DeficiencyAfibrinogenemiaBleedingBlood Coagulation DisordersCardiac Surgical ProceduresCoagulopathyCongenital Heart DiseaseCryoprecipitate
Phase 2
Fibrinogen Concentrate In Children After Cardiac Surgery
CompletedNCT01187225
Start: 2010-08-31End: 2011-11-30Updated: 2013-01-04
Fibrinogen Early In Severe Trauma studY
CompletedNCT02745041
Start: 2016-12-31End: 2018-02-20Updated: 2018-03-05
Fibrinogen Early In Severe Trauma studY Junior
NCT03508141
Start: 2018-07-01End: 2021-06-30Target: 44Updated: 2020-06-29
Phase 3
Fibrinogen Concentrate (Human) - Efficacy and Safety Study
WithdrawnNCT00916656
Start: 2009-10-31End: 2014-03-31Updated: 2023-02-06
FIBrinogen REplenishment in Surgery
CompletedNCT03037424
Start: 2017-02-22End: 2019-03-27Updated: 2019-05-14
In Vivo Effects of Fibrinogen Concentrate (FC) Versus Cryoprecipitate on the Neonatal Fibrin Network Structure After Cardiopulmonary Bypass (CPB)
CompletedNCT03932240
Start: 2019-08-13End: 2021-11-16Updated: 2024-02-20
Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation
CompletedNCT04704869
Start: 2017-01-31End: 2022-11-01Updated: 2025-01-14
Fibrinogen Early In Severe Trauma StudY II
RecruitingNCT05449834
Start: 2022-11-21End: 2026-12-01Target: 900Updated: 2026-02-05
Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery
RecruitingNCT06617897
Start: 2024-10-01End: 2027-10-29Target: 90Updated: 2026-03-11